HIV vaccine - China National Biotech Group
Latest Information Update: 31 Oct 2021
At a glance
- Originator China National Biotec Group
- Class AIDS vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported HIV infections
Most Recent Events
- 28 Feb 2019 No recent reports of development identified for clinical-Phase-Unknown development in HIV-infections in China (Parenteral)
- 28 Feb 2019 No recent reports of development identified for clinical-Phase-Unknown development in HIV-infections(Prevention) in China (Parenteral)
- 19 Jan 2016 Clinical trials in HIV infections (Prevention) in China (Parenteral) prior to January 2016